文传商讯
Merck Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manif
2026-05-07 00:36:13
Il Gruppo Chiesi acquisisce KalVista Pharmaceuticals, rafforzando il portafoglio globale nelle Malat
2026-04-30 22:59:01
Hytera to Host Global Partner Summit 2026 in Shanghai, Advancing AI-Powered Mission-Critical Communi
2026-04-30 22:59:01
Samsung Bioepis and ATLATL Sign Memorandum of Understanding (MoU) to Accelerate Early-Stage Biotech
2026-04-30 22:59:01



